HEMA:PA:PA-HSBC MSCI Emerging Markets UCITS ETF USD Acc EUR (EUR)

ETF | Others |

Last Closing

USD 10.31

Change

-0.04 (-0.39)%

Market Cap

N/A

Volume

10.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.60 (-1.30%)

USD 61.43B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-2.30 (-0.45%)

USD 12.30B
WRD:PA HSBC ETFs Public Limited Compa..

-0.16 (-0.47%)

USD 9.84B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-1.19 (-0.49%)

USD 8.53B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-2.20 (-0.51%)

USD 7.74B
HHH:PA HSBC ETFs Public Limited Compa..

-0.22 (-0.43%)

USD 6.87B
WLD:PA Lyxor UCITS MSCI World D-EUR

-1.62 (-0.49%)

USD 6.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.09 (-0.53%)

USD 6.16B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-1.63 (-0.45%)

USD 4.86B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-0.61 (-0.42%)

USD 4.57B

ETFs Containing HEMA:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.62% 47% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.62% 44% F 60% D-
Trailing 12 Months  
Capital Gain 9.45% 39% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.45% 36% F 57% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.22% 36% F 45% F
Dividend Return 3.22% 51% F 42% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.31% 83% B 93% A
Risk Adjusted Return 60.70% 51% F 73% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike